Hans-Georg Rammensee
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Wyss N, Berner F, Walter V, Jochum A, Purde M, Abdou M, Sinnberg T, Hofmeister K, Pop O, Hasan A, Bauer J, Cheng H, Lütge M, Klümper N, Diem S, Kosaloglu-Yalcin Z, Zhang Y, Sellmer L, Macek B, Karbach J, König D, Läubli H, Zender L, Meyer B, Driessen C, Schürch C, Jochum W, Amaral T, Heinzerling L, Cozzio A, Hegazy A, Schneider T, Brutsche M, Sette A, Lenz T, Walz J, Rammensee H, Früh M, Jäger E, Becher B, Tufman A, Núñez N, Jörger M, Flatz L. Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade. Am J Respir Crit Care Med 2024; 210:919-930.
01.10.2024Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
01.10.2024Am J Respir Crit Care Med 2024; 210:919-930
Wyss Nina, Berner Fiamma, Walter Vincent, Jochum Ann-Kristin, Purde Mette T, Abdou Marie-Therese, Sinnberg Tobias, Hofmeister Kathrin, Pop Oltin, Hasan Ali, Bauer Jens, Cheng Hung-Wei, Lütge Mechthild, Klümper Niklas, Diem Stefan, Kosaloglu-Yalcin Zeynep, Zhang Yizheng, Sellmer Laura, Macek Boris, Karbach Julia, König David, Läubli Heinz, Zender Lars, Meyer Britta S, Driessen Christoph, Schürch Christian M, Jochum Wolfram, Amaral Teresa, Heinzerling Lucie M, Cozzio Antonio, Hegazy AhN, Schneider Tino, Brutsche Martin, Sette Alessandro, Lenz Tobias L, Walz Juliane Sarah, Rammensee Hans-Georg, Früh Martin, Jäger Elke, Becher Burkhard, Tufman Amanda, Núñez Nicolás Gonzalo, Jörger Markus, Flatz Lukas
TOF mass spectrometry-based immunopeptidomics refines tumor antigen identification.
Hoenisch Gravel N, Nelde A, Bauer J, Mühlenbruch L, Schroeder S, Neidert M, Scheid J, Lemke S, Dubbelaar M, Wacker M, Dengler A, Klein R, Mauz P, Löwenheim H, Hauri-Hohl M, Martin R, Hennenlotter J, Stenzl A, Heitmann J, Salih H, Rammensee H, Walz J. TOF mass spectrometry-based immunopeptidomics refines tumor antigen identification. Nat Commun 2023; 14:7472.
17.11.2023TOF mass spectrometry-based immunopeptidomics refines tumor antigen identification.
17.11.2023Nat Commun 2023; 14:7472
Hoenisch Gravel Naomi, Nelde Annika, Bauer Jens, Mühlenbruch Lena, Schroeder Sarah M, Neidert Marian Christoph, Scheid Jonas, Lemke Steffen, Dubbelaar MariLisa, Wacker Marcel, Dengler Anna, Klein Reinhild, Mauz Paul-Stefan, Löwenheim Hubert, Hauri-Hohl Mathias, Martin Roland, Hennenlotter Jörg, Stenzl Arnulf, Heitmann Jonas S, Salih Helmut Rainer, Rammensee Hans-Georg, Walz Juliane Sarah
A T-cell antigen atlas for meningioma: novel options for immunotherapy.
Medici G, Freudenmann L, Velz J, Wang S, Kapolou K, Paramasivam N, Mühlenbruch L, Kowalewski D, Vasella F, Bilich T, Frey B, Dubbelaar M, Patterson A, Zeitlberger A, Silginer M, Roth P, Weiss T, Wirsching H, Krayenbühl N, Bozinov O, Regli L, Rammensee H, Rushing E, Sahm F, Walz J, Weller M, Neidert M. A T-cell antigen atlas for meningioma: novel options for immunotherapy. Acta Neuropathol 2023; 146:173-190.
27.06.2023A T-cell antigen atlas for meningioma: novel options for immunotherapy.
27.06.2023Acta Neuropathol 2023; 146:173-190
Medici Gioele, Freudenmann Lena Katharina, Velz Julia, Wang Sophie Shih-Yüng, Kapolou Konstantina, Paramasivam Nagarajan, Mühlenbruch Lena, Kowalewski Daniel Johannes, Vasella Flavio, Bilich Tatjana, Frey Beat M, Dubbelaar MariLisa, Patterson Angelica Brooke, Zeitlberger Anna Maria, Silginer Manuela, Roth Patrick, Weiss Tobias, Wirsching Hans-Georg, Krayenbühl Niklaus, Bozinov Oliver, Regli Luca, Rammensee Hans-Georg, Rushing Elisabeth Jane, Sahm Felix, Walz Juliane Sarah, Weller Michael, Neidert Marian Christoph
Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma.
Naghavian R, Faigle W, Oldrati P, Wang J, Toussaint N, Qiu Y, Medici G, Wacker M, Freudenmann L, Bonté P, Weller M, Regli L, Amigorena S, Rammensee H, Walz J, Brugger S, Mohme M, Zhao Y, Sospedra M, Neidert M, Martin R. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma. Nature 2023; 617:807-817.
17.05.2023Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma.
17.05.2023Nature 2023; 617:807-817
Naghavian Reza, Faigle Wolfgang, Oldrati Pietro, Wang Jianwen, Toussaint Nora C, Qiu Yuhan, Medici Gioele, Wacker Marcel, Freudenmann Lena Katharina, Bonté Pierre-Emmanuel, Weller Michael, Regli Luca, Amigorena Sebastian, Rammensee Hans-Georg, Walz Juliane Sarah, Brugger Silvio D, Mohme Malte, Zhao Yingdong, Sospedra Mireia, Neidert Marian Christoph, Martin Roland
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.
Berner F, Bomze D, Lichtensteiger C, Walter V, Niederer R, Hasan Ali O, Wyss N, Bauer J, Freudenmann L, Marcu A, Wolfschmitt E, Haen S, Gross T, Abdou M, Diem S, Knöpfli S, Sinnberg T, Hofmeister K, Cheng H, Toma M, Klümper N, Purde M, Pop O, Jochum A, Pascolo S, Jörger M, Früh M, Jochum W, Rammensee H, Läubli H, Hölzel M, Neefjes J, Walz J, Flatz L. Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade. Sci Immunol 2022; 7:eabn9644.
02.09.2022Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.
02.09.2022Sci Immunol 2022; 7:eabn9644
Berner Fiamma, Bomze David, Lichtensteiger Christa, Walter Vincent, Niederer Rebekka, Hasan Ali Omar, Wyss Nina, Bauer Jens, Freudenmann Lena Katharina, Marcu Ana, Wolfschmitt Eva-Maria, Haen Sebastian, Gross Thorben, Abdou Marie-Therese, Diem Stefan, Knöpfli Stella, Sinnberg Tobias, Hofmeister Kathrin, Cheng Hung-Wei, Toma Marieta, Klümper Niklas, Purde Mette-Triin, Pop Oltin Tiberiu, Jochum Ann-Kristin, Pascolo Steve, Jörger Markus, Früh Martin, Jochum Wolfram, Rammensee Hans-Georg, Läubli Heinz, Hölzel Michael, Neefjes Jacques, Walz Juliane, Flatz Lukas
Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues.
Kubiniok P, Marcu A, Bichmann L, Kuchenbecker L, Schuster H, Hamelin D, Duquette J, Kovalchik K, Wessling L, Kohlbacher O, Rammensee H, Neidert M, Sirois I, Caron E. Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues. iScience 2022; 25:103768.
18.01.2022Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues.
18.01.2022iScience 2022; 25:103768
Kubiniok Peter, Marcu Ana, Bichmann Leon, Kuchenbecker Leon, Schuster Heiko, Hamelin David J, Duquette Jérôme D, Kovalchik Kevin A, Wessling Laura, Kohlbacher Oliver, Rammensee Hans-Georg, Neidert Marian C, Sirois Isabelle, Caron Etienne
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
Berner F, Niederer R, Luimstra J, Pop O, Jochum A, Purde M, Hasan Ali O, Bomze D, Bauer J, Freudenmann L, Marcu A, Wolfschmitt E, Haen S, Gross T, Dubbelaar M, Abdou M, Baumgaertner P, Appenzeller C, Cicin-Sain C, Lenz T, Speiser D, Ludewig B, Driessen C, Jörger M, Früh M, Jochum W, Cozzio A, Rammensee H, Walz J, Neefjes J, Flatz L. Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival. Oncoimmunology 2021; 10:2006893.
27.11.2021Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
27.11.2021Oncoimmunology 2021; 10:2006893
Berner Fiamma, Niederer Rebekka, Luimstra Jolien J, Pop Oltin Tiberiu, Jochum Ann-Kristin, Purde Mette-Triin, Hasan Ali Omar, Bomze David, Bauer Jens, Freudenmann Lena Katharina, Marcu Ana, Wolfschmitt Eva-Maria, Haen Sebastian, Gross Thorben, Dubbelaar MariLisa, Abdou Marie-Therese, Baumgaertner Petra, Appenzeller Christina, Cicin-Sain Caroline, Lenz Tobias, Speiser Daniel E, Ludewig Burkhard, Driessen Christoph, Jörger Markus, Früh Martin, Jochum Wolfram, Cozzio Antonio, Rammensee Hans-Georg, Walz Juliane, Neefjes Jacques, Flatz Lukas
Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
Nelde A, Rammensee H, Aulitzky W, Illerhaus G, Denzlinger C, Neidert M, Bauer J, Marcu A, Heitmann J, Roerden M, Salih H, Bilich T, Maringer Y, Walz J. Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia. Front Immunol 2021; 12:705974.
08.07.2021Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
08.07.2021Front Immunol 2021; 12:705974
Nelde Annika, Rammensee Hans-Georg, Aulitzky Walter Erich, Illerhaus Gerald, Denzlinger Claudio, Neidert Marian Christoph, Bauer Jens, Marcu Ana, Heitmann Jonas S, Roerden Malte, Salih Helmut R, Bilich Tatjana, Maringer Yacine, Walz Juliane S
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
Bilich T, Flatz L, Held S, Brossart P, Märklin M, Wagner P, Erne E, Klein R, Rammensee H, Salih H, Berner F, Wacker M, Roerden M, Maringer Y, Nelde A, Heitmann J, Dubbelaar M, Peter A, Hörber S, Bauer J, Rieth J, Walz J. Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer. Cancer Discov 2021; 11:1982-1995.
19.05.2021Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
19.05.2021Cancer Discov 2021; 11:1982-1995
Bilich Tatjana, Flatz Lukas, Held Stefanie, Brossart Peter, Märklin Melanie, Wagner Philipp, Erne Eva, Klein Reinhild, Rammensee Hans-Georg, Salih Helmut R, Berner Fiamma, Wacker Marcel, Roerden Malte, Maringer Yacine, Nelde Annika, Heitmann Jonas S, Dubbelaar Marissa L, Peter Andreas, Hörber Sebastian, Bauer Jens, Rieth Jonas, Walz Juliane S
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
Marcu A, Walz J, Velz J, Moch H, Regli L, Silginer M, Weller M, Löffler M, Erhard F, Schlosser A, Kohlbacher O, Stevanovic S, Rammensee H, Kapolou K, Martin R, Hauri-Hohl M, Bichmann L, Kuchenbecker L, Kowalewski D, Freudenmann L, Backert L, Mühlenbruch L, Szolek A, Lübke M, Wagner P, Engler T, Matovina S, Wang J, Neidert M. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy. J Immunother Cancer 2021; 9
01.01.2021HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
01.01.2021J Immunother Cancer 2021; 9
Marcu Ana, Walz Juliane Sarah, Velz Julia, Moch Holger, Regli Luca, Silginer Manuela, Weller Michael, Löffler Markus W, Erhard Florian, Schlosser Andreas, Kohlbacher Oliver, Stevanovic Stefan, Rammensee Hans-Georg, Kapolou Konstantina, Martin Roland, Hauri-Hohl Mathias, Bichmann Leon, Kuchenbecker Leon, Kowalewski Daniel Johannes, Freudenmann Lena Katharina, Backert Linus, Mühlenbruch Lena, Szolek András, Lübke Maren, Wagner Philipp, Engler Tobias, Matovina Sabine, Wang Jian, Neidert Marian Christoph
Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
Bilich T, Stevanovic S, Rammensee H, Neidert M, Schuhmacher J, Lübke M, Marcu A, Besemer B, Weisel K, Salih H, Roerden M, Walz S, Bauer J, Nelde A, Walz J. Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma. Blood Cancer J 2020; 10:24.
28.02.2020Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
28.02.2020Blood Cancer J 2020; 10:24
Bilich Tatjana, Stevanovic Stefan, Rammensee Hans-Georg, Neidert Marian Christoph, Schuhmacher Juliane, Lübke Maren, Marcu Ana, Besemer Britta, Weisel Katja, Salih Helmut R, Roerden Malte, Walz Simon, Bauer Jens, Nelde Annika, Walz Juliane S
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
Bilich T, Vucinic V, Niederwieser D, Bauer J, Märklin M, Peper J, Klein R, Kohlbacher O, Kanz L, Rammensee H, Stevanovic S, Brümmendorf T, Schemionek M, Rieth J, Nelde A, Bichmann L, Roerden M, Salih H, Kowalewski D, Schuster H, Tsou C, Marcu A, Neidert M, Lübke M, Walz J. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy. Blood 2018; 133:550-565.
10.12.2018The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
10.12.2018Blood 2018; 133:550-565
Bilich Tatjana, Vucinic Vladan, Niederwieser Dietger, Bauer Jens, Märklin Melanie, Peper Janet K, Klein Reinhild, Kohlbacher Oliver, Kanz Lothar, Rammensee Hans-Georg, Stevanovic Stefan, Brümmendorf Tim H, Schemionek Mirle, Rieth Jonas, Nelde Annika, Bichmann Leon, Roerden Malte, Salih Helmut R, Kowalewski Daniel J, Schuster Heiko, Tsou Chih-Chiang, Marcu Ana, Neidert Marian Christoph, Lübke Maren, Walz Juliane S
The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy
Neidert M, Rammensee H, Henschler R, Lamszus K, Westphal M, Roth P, Regli L, Stevanovic S, Weller M, Wolpert F, Walz J, Kowalewski D, Silginer M, Kapolou K, Backert L, Freudenmann L, Peper J, Marcu A, Wang S, Eisele G. The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy. Acta Neuropathol 2018; 135:923-938.
20.03.2018The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy
20.03.2018Acta Neuropathol 2018; 135:923-938
Neidert Marian Christoph, Rammensee Hans-Georg, Henschler Reinhard, Lamszus Katrin, Westphal Manfred, Roth Patrick, Regli Luca, Stevanovic Stefan, Weller Michael, Wolpert Fabian, Walz Juliane Sarah, Kowalewski Daniel Johannes, Silginer Manuela, Kapolou Konstantina, Backert Linus, Freudenmann Lena Katharina, Peper Janet Kerstin, Marcu Ana, Wang Sophie Shih-Yüng, Eisele Günter
A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and "pan-leukemia" antigens
Backert L, Stevanovic S, Rammensee H, Weisel K, Kohlbacher O, Salih H, Kanz L, Niederwieser D, Vucinic V, Brümmendorf T, Schemionek M, Neidert M, Berlin C, Schuster H, Walz S, Kowalewski D, Walz J. A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and "pan-leukemia" antigens. Oncotarget 2017; 8:43915-43924.
04.07.2017A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and "pan-leukemia" antigens
04.07.2017Oncotarget 2017; 8:43915-43924
Backert Linus, Stevanovic Stefan, Rammensee Hans-Georg, Weisel Katja, Kohlbacher Oliver, Salih Helmut Rainer, Kanz Lothar, Niederwieser Dietger, Vucinic Vladan, Brümmendorf Tim H, Schemionek Mirle, Neidert Marian Christoph, Berlin Claudia, Schuster Heiko, Walz Simon, Kowalewski Daniel Johannes, Walz Juliane Sarah
Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells
Skabytska Y, Götz F, Röcken M, Schaller M, Rammensee H, Volz T, Kempf W, Demircioglu D, Guenova E, Chen K, Kaesler S, Köberle M, Günther C, Wölbing F, Biedermann T. Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Immunity 2014; 41:762-75.
13.11.2014Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells
13.11.2014Immunity 2014; 41:762-75
Skabytska Yuliya, Götz Friedrich, Röcken Martin, Schaller Martin, Rammensee Hans-Georg, Volz Thomas, Kempf Wolfgang E, Demircioglu Doruk, Guenova Emmanuella, Chen Ko-Ming, Kaesler Susanne, Köberle Martin, Günther Claudia, Wölbing Florian, Biedermann Tilo
Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy
Neidert M, Dietrich P, Herold-Mende C, Rammensee H, Honegger J, Melms A, Christ L, Trautwein N, Trautwein C, Schoor O, Stevanovic S. Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy. J Neurooncol 2012; 111:285-94.
23.12.2012Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy
23.12.2012J Neurooncol 2012; 111:285-94
Neidert Marian Christoph, Dietrich Pierre-Yves, Herold-Mende Christel, Rammensee Hans-Georg, Honegger Jürgen, Melms Arthur, Christ Lisa, Trautwein Nico, Trautwein Claudia, Schoor Oliver, Stevanovic Stefan
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins
Dengjel J, Rammensee H, Driessen C, Brock R, Kalbacher H, Brandenburg J, Altenberend F, Kreymborg K, Müller M, Kraus M, Reich M, Fischer R, Schoor O, Stevanovic S. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proceedings of the National Academy of Sciences of the United States of America 2005; 102:7922-7.
31.05.2005Autophagy promotes MHC class II presentation of peptides from intracellular source proteins
31.05.2005Proceedings of the National Academy of Sciences of the United States of America 2005; 102:7922-7
Dengjel Jörn, Rammensee Hans-Georg, Driessen Christoph, Brock Roland, Kalbacher Hubert, Brandenburg Jens, Altenberend Florian, Kreymborg Katharina, Müller Margret, Kraus Marianne, Reich Michael, Fischer Rainer, Schoor Oliver, Stevanovic Stefan